Ozagrel

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Ozagrel
Ozagrel.png
Clinical data
AHFS/Drugs.comInternational Drug Names
Routes of
administration
Oral
ATC code
  • none
Legal status
Legal status
  • In general: ℞ (Prescription only)
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.122.039 Edit this at Wikidata
Chemical and physical data
FormulaC13H12N2O2
Molar mass228.24 g/mol g·mol−1
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

Ozagrel (INN) is an antiplatelet agent working as a thromboxane A2 synthesis inhibitor.[1]

References[edit]

  1. ^ Loo MH, Egan D, Vaughan ED, Marion D, Felsen D, Weisman S (March 1987). "The effect of the thromboxane A2 synthesis inhibitor OKY-046 on renal function in rabbits following release of unilateral ureteral obstruction". J. Urol. 137 (3): 571–6. PMID 3820396.